IntegraGen SA (ALINT.PA) Stock Price
€0.31 3.1%
to add to portfolio
AI Score

-
Alternative
6 -
Fundamental
8 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on IntegraGen SA, AI stock picks, stock alerts and much more.
ALINT.PA AI Stock Analysis
AI stock analysis for ALINT.PA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like IntegraGen SA (ALINT.PA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
IntegraGen SA (ALINT.PA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of IntegraGen SA (ALINT.PA), currently trading at €0.31, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ALINT.PA

-
IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France.
-
Symbol
ALINT.PA
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
2.1M
Similar Stocks
![]() |
Valneva SE VLA.PA |
€5.07 6.1% |
5 |
![]() |
Financière de Tubize SA TUB.BR |
€160 1.7% |
8 |
![]() |
OSE Immunotherapeutics SA OSE.PA |
€6.91 4.1% |
7 |
![]() |
UCB SA UCB.BR |
€195.5 1.5% |
6 |
![]() |
Innate Pharma S.A. IPH.PA |
€1.99 1.4% |
6 |
News
No news articles.
ALINT.PA Alternative Data
Web Traffic
IntegraGen SA receives an estimated 637 monthly visitors to integragen.com.
-
Web Traffic
637
-
Change from Previous Month
153.8%
-
3 Month Change
126.7%
-
YoY Change
126.7%
Twitter Followers
IntegraGen SA has 624 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.5% over the last month.
-
Twitter Followers
624
-
Daily Change
0%
-
1 Month Change
0.5%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Facebook Engagement
IntegraGen SA has engaged 2 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
2
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Instagram Followers
IntegraGen SA has 66 Instagram Followers on its main Instagram account.
-
Instagram Followers
66
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
IntegraGen SA currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, IntegraGen SA has 52 employees, up by 2% over the last month.
-
LinkedIn Employees
52
-
Daily Change
2%
-
1 Month Change
2%
-
3 Month Change
6.1%
-
YoY Change
6.1%
Business Outlook
According to employee reviews, the business outlook among employees at IntegraGen SA is 100 out of 100 (very bullish).
-
Business Outlook
100
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
News Mentions
IntegraGen SA was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Reddit Mentions
IntegraGen SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
1 Month Change
0%
-
3 Month Change
0%
ALINT.PA Financials
ALINT.PA Key Metrics
-
Total Revenue
€4.1M
-
Net Income
-€140.4K
-
Earnings per Share
-€0.0209
-
Free cash flow
€0
-
EBITDA
-€1.8M
-
EBITDA Ratio
-0.432925
-
Total Assets
€5.5M
ALINT.PA 2-year Revenue & Income
ALINT.PA 2-year Free Cash Flow
ALINT.PA Technicals
ALINT.PA SMA
ALINT.PA RSI
FAQ
What's the current price of IntegraGen SA (ALINT.PA) Stock?
The price of an IntegraGen SA (ALINT.PA) share is €0.31.
What's the market cap of IntegraGen SA?
The current market cap of IntegraGen SA is 2.1M.
Should I buy or sell ALINT.PA?
IntegraGen SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, IntegraGen SA is better viewed as a hold or accumulate position while waiting for further developments.
Is IntegraGen SA a good investment?
The current analysis of IntegraGen SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in IntegraGen SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy IntegraGen SA (ALINT.PA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for IntegraGen SA stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to IntegraGen SA (ALINT.PA) that investors often compare it to?
IntegraGen SA (ALINT.PA) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..
What is the forecast for IntegraGen SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast IntegraGen SA's stock price to be around €0.329 in 2026. Starting from the current price of €0.31, this represents a 6.1% change in price, indicating a bullish outlook for the stock.
How to buy IntegraGen SA (ALINT.PA) Stock?
IntegraGen SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy IntegraGen SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.